An IL-10/DEL-1 axis supports granulopoiesis and survival from sepsis in early life.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
23 Jan 2024
Historique:
received: 24 10 2021
accepted: 03 12 2023
medline: 24 1 2024
pubmed: 24 1 2024
entrez: 23 1 2024
Statut: epublish

Résumé

The limited reserves of neutrophils are implicated in the susceptibility to infection in neonates, however the regulation of neutrophil kinetics in infections in early life remains poorly understood. Here we show that the developmental endothelial locus (DEL-1) is elevated in neonates and is critical for survival from neonatal polymicrobial sepsis, by supporting emergency granulopoiesis. Septic DEL-1 deficient neonate mice display low numbers of myeloid-biased multipotent and granulocyte-macrophage progenitors in the bone marrow, resulting in neutropenia, exaggerated bacteremia, and increased mortality; defects that are rescued by DEL-1 administration. A high IL-10/IL-17A ratio, observed in newborn sepsis, sustains tissue DEL-1 expression, as IL-10 upregulates while IL-17 downregulates DEL-1. Consistently, serum DEL-1 and blood neutrophils are elevated in septic adult and neonate patients with high serum IL-10/IL-17A ratio, and mortality is lower in septic patients with high serum DEL-1. Therefore, IL-10/DEL-1 axis supports emergency granulopoiesis, prevents neutropenia and promotes sepsis survival in early life.

Identifiants

pubmed: 38263289
doi: 10.1038/s41467-023-44178-y
pii: 10.1038/s41467-023-44178-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

680

Informations de copyright

© 2024. The Author(s).

Références

Gaieski, D. F. et al. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit. Care Med. 41, 1167–1174 (2013).
pubmed: 23442987 doi: 10.1097/CCM.0b013e31827c09f8
Camacho-Gonzalez, A. et al. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr. Clin. North Am. 60, 367–389 (2013).
pubmed: 23481106 pmcid: 4405627 doi: 10.1016/j.pcl.2012.12.003
Vergadi, E. et al. Changes in the incidence and epidemiology of neonatal group B Streptococcal disease over the last two decades in Crete, Greece. Infect. Dis. Rep. 10, 7744 (2018).
pubmed: 30662690 pmcid: 6315311 doi: 10.4081/idr.2018.7744
Levy, O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7, 379–390 (2007).
pubmed: 17457344 doi: 10.1038/nri2075
Angelone, D. F. et al. Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo. Pediatr. Res. 60, 205–209 (2006).
pubmed: 16864705 doi: 10.1203/01.pdr.0000228319.10481.ea
Stearns-Kurosawa, D. J. et al. The pathogenesis of sepsis. Annu. Rev. Pathol. 6, 19–48 (2011).
pubmed: 20887193 pmcid: 3684427 doi: 10.1146/annurev-pathol-011110-130327
Wynn, J. L. et al. Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood. 112, 1750–1758 (2008).
pubmed: 18591384 pmcid: 2518883 doi: 10.1182/blood-2008-01-130500
Chavakis, E. et al. Novel aspects in the regulation of the leukocyte adhesion cascade. Thromb. Haemost. 102, 191–197 (2009).
pubmed: 19652868 pmcid: 2722029 doi: 10.1160/TH08-12-0844
Kovach, M. A. et al. The function of neutrophils in sepsis. Curr. Opin. Infect. Dis. 25, 321–327 (2012).
pubmed: 22421753 doi: 10.1097/QCO.0b013e3283528c9b
Buschmann, K. et al. RAGE controls leukocyte adhesion in preterm and term infants. BMC Immunol. 15, 53 (2014).
pubmed: 25428166 pmcid: 4256735 doi: 10.1186/s12865-014-0053-0
Bracho, F. et al. Potential use of granulocyte colon-stimulating factor and granulocyte-macrophage colony-stimulating factor in neonates. Curr. Opin. Hematol. 5, 215–220 (1998).
pubmed: 9664163 doi: 10.1097/00062752-199805000-00012
Cuenca, A. G. et al. Delayed emergency myelopoiesis following polymicrobial sepsis in neonates. Innate Immun. 21, 386–391 (2015).
pubmed: 25106654 doi: 10.1177/1753425914542445
Hajishengallis, G. et al. DEL-1-regulated immune plasticity and inflammatory disorders. Trends Mol. Med. 25, 444–459 (2019).
pubmed: 30885428 pmcid: 6488420 doi: 10.1016/j.molmed.2019.02.010
Choi, E. Y. et al. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 322, 1101–1104 (2008).
pubmed: 19008446 pmcid: 2753175 doi: 10.1126/science.1165218
Hajishengallis, G. et al. Endogenous modulators of inflammatory cell recruitment. Trends Immunol. 34, 1–6 (2013).
pubmed: 22951309 doi: 10.1016/j.it.2012.08.003
Schurpf, T. et al. The RGD finger of Del-1 is a unique structural feature critical for integrin binding. FASEB J. 26, 3412–3420 (2012).
pubmed: 22601780 pmcid: 3405271 doi: 10.1096/fj.11-202036
Vestweber, D. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol. Rev. 218, 178–196 (2007).
pubmed: 17624953 doi: 10.1111/j.1600-065X.2007.00533.x
Kourtzelis, I. et al. DEL-1 promotes macrophage efferocytosis and clearance of inflammation. Nat. Immunol. 20, 40–49 (2019).
pubmed: 30455459 doi: 10.1038/s41590-018-0249-1
Li, X. et al. The DEL-1/beta3 integrin axis promotes regulatory T cell responses during inflammation resolution. J. Clin. Investig. 130, 6261–6277 (2020).
pubmed: 32817592 pmcid: 7685741 doi: 10.1172/JCI137530
Eskan, M. A. et al. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat. Immunol. 13, 465–473 (2012).
pubmed: 22447028 pmcid: 3330141 doi: 10.1038/ni.2260
Choi, E. Y. et al. Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination. Mol. Psychiatry 20, 880–888 (2015).
pubmed: 25385367 doi: 10.1038/mp.2014.146
Shin, J. et al. DEL-1 restrains osteoclastogenesis and inhibits inflammatory bone loss in nonhuman primates. Sci. Transl. Med. 7, 307ra155 (2015).
pubmed: 26424570 pmcid: 4593066 doi: 10.1126/scitranslmed.aac5380
Mitroulis, I. et al. Secreted protein Del-1 regulates myelopoiesis in the hematopoietic stem cell niche. J. Clin. Investig. 127, 3624–3639 (2017).
pubmed: 28846069 pmcid: 5617665 doi: 10.1172/JCI92571
Shin, J. et al. Expression and function of the homeostatic molecule Del-1 in endothelial cells and the periodontal tissue. Clin. Dev. Immunol. 2013, 617809 (2013).
pubmed: 24416060 pmcid: 3876683 doi: 10.1155/2013/617809
Kanczkowski, W. et al. Role of the endothelial-derived endogenous anti-inflammatory factor Del-1 in inflammation-mediated adrenal gland dysfunction. Endocrinology 154, 1181–1189 (2013).
pubmed: 23364949 doi: 10.1210/en.2012-1617
Kang, Y. Y. et al. Deficiency of developmental endothelial locus-1 (Del-1) aggravates bleomycin-induced pulmonary fibrosis in mice. Biochem. Biophys. Res. Commun. 445, 369–374 (2014).
pubmed: 24525119 doi: 10.1016/j.bbrc.2014.02.009
Wynn, J. L. et al. Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock 28, 675–683 (2007).
pubmed: 17621256 doi: 10.1097/shk.0b013e3180556d09
Levy, O. Impaired innate immunity at birth: deficiency of bactericidal/permeability-increasing protein (BPI) in the neutrophils of newborns. Pediatr. Res. 51, 667–669 (2002).
pubmed: 12032258 doi: 10.1203/00006450-200206000-00001
Drossou, V. et al. Concentrations of main serum opsonins in early infancy. Arch. Dis. Child Fetal Neonatal Ed. 72, F172–F175 (1995).
pubmed: 7796232 pmcid: 2528447 doi: 10.1136/fn.72.3.F172
Conly, M. E. & Speert, D. P. Human neonatal monocyte-derived macrophages and neutrophils exhibit normal nonopsonic and opsonic receptor-mediated phagocytosis and superoxide anion production. Biol Neonate. 60, 361–366 (1991).
pubmed: 1665710 doi: 10.1159/000243433
Gille, C. H. et al. Phagocytosis and postphagocytic reaction of cord blood and adult blood monocyte after infection with green fluorescent protein-labeled Escherichia coli and group B Streptococci. Cytometry B Clin. Cytom. 76, 271–284 (2009).
pubmed: 19288547 doi: 10.1002/cyto.b.20474
Suratt, B. T. et al. Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis. Blood. 104, 565–571 (2004).
pubmed: 15054039 doi: 10.1182/blood-2003-10-3638
Mitroulis, I. et al. Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell 172, 147–161.e12 (2018).
pubmed: 29328910 pmcid: 5766828 doi: 10.1016/j.cell.2017.11.034
Barman, P. K. & Goodridge, H. S. Microbial sensing by hematopoietic stem and progenitor cells. Stem Cells 40, 14–21 (2022).
pubmed: 35511863 pmcid: 9072977 doi: 10.1093/stmcls/sxab007
Pietras, E. M. et al. Functionally distinct subsets of lineage-biased multipotent progenitors control blood production in normal and regenerative conditions. Cell Stem Cell. 17, 35–46 (2015).
pubmed: 26095048 pmcid: 4542150 doi: 10.1016/j.stem.2015.05.003
Chavakis, T. et al. Inflammatory modulation of hematopoiesis: linking trained immunity and clonal hematopoiesis with chronic disorders. Annu. Rev. Physiol. 84, 183–207 (2022).
pubmed: 34614373 doi: 10.1146/annurev-physiol-052521-013627
Köhler, A. et al. G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands. Blood 117, 4349–4357 (2011).
pubmed: 21224471 pmcid: 3087483 doi: 10.1182/blood-2010-09-308387
Maekawa, T. et al. Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3beta-C/EBPbeta pathway. Nat. Commun. 6, 8272 (2015).
pubmed: 26374165 doi: 10.1038/ncomms9272
Ziogas, A. et al. DHEA inhibits leukocyte recruitment through regulation of the integrin antagonist DEL-1. J. Immunol. 204, 1214–1224 (2020).
pubmed: 31980574 pmcid: 7026770 doi: 10.4049/jimmunol.1900746
Li, M., Zhong, D. & Li, G. Regulatory role of local tissue signal Del-1 in cancer and inflammation: a review. Cell Mol. Biol. Lett. 26, 31 (2021).
pubmed: 34217213 pmcid: 8254313 doi: 10.1186/s11658-021-00274-9
Wang, H. et al. Stromal cell-derived DEL-1 inhibits Tfh cell activation and inflammatory arthritis. J. Clin. Investig. 1, 131:e150578 (2021).
Kim, W. Y. et al. Serum developmental endothelial locus-1 is associated with severity of sepsis in animals and humans. Sci. Rep. 9, 13005 (2019).
pubmed: 31506547 pmcid: 6737092 doi: 10.1038/s41598-019-49564-5
Sperandio, M. et al. Ontogenetic regulation of leukocyte recruitment in mouse yolk sac vessels. Blood 121, e118–e128 (2013).
pubmed: 23525796 pmcid: 3713423 doi: 10.1182/blood-2012-07-447144
Nussbaum, C. et al. Neutrophil and endothelial adhesive function during human fetal ontogeny. J. Leukoc. Biol. 93, 175–184 (2013).
pubmed: 23233729 pmcid: 4050519 doi: 10.1189/jlb.0912468
Basha, S. et al. Immune responses in neonates. Expert Rev. Clin. Immunol. 10, 1171–1184 (2014).
pubmed: 25088080 pmcid: 4407563 doi: 10.1586/1744666X.2014.942288
Rebuck, N. et al. Neutrophil adhesion molecules in term and premature infants: normal or enhanced leucocyte integrins but defective L-selectin expression and shedding. Clin. Exp. Immunol. 101, 183–189 (1995).
pubmed: 7542575 pmcid: 1553291 doi: 10.1111/j.1365-2249.1995.tb02296.x
Hidalgo, A. et al. Enforced fucosylation of neonatal CD34+ cells generates selectin ligands that enhance the initial interactions with microvessels but not homing to bone marrow. Blood. 105, 567–575 (2005).
pubmed: 15367439 doi: 10.1182/blood-2004-03-1026
van Griensven, M. et al. Leukocyte-endothelial interactions via ICAM-1 are detrimental in polymicrobial sepsis. Shock 25, 254–259 (2006).
pubmed: 16552357 doi: 10.1097/01.shk.0000196497.49683.13
Phillipson, M. et al. The neutrophil in vascular inflammation. Nat. Med. 17, 1381–1390 (2011).
pubmed: 22064428 pmcid: 7095830 doi: 10.1038/nm.2514
Vergadi, E. et al. Akt2 deficiency protects from acute lung injury via alternative macrophage activation and miR-146a induction in mice. J. Immunol. 192, 394–406 (2014).
pubmed: 24277697 doi: 10.4049/jimmunol.1300959
Grommes, J. et al. Contribution of neutrophils to acute lung injury. Mol. Med. 17, 293–307 (2011).
pubmed: 21046059 doi: 10.2119/molmed.2010.00138
Williams, A. E. et al. The mercurial nature of neutrophils: still an enigma in ARDS? Am. J. Physiol. Lung Cell Mol. Physiol. 306, L217–L230 (2014).
pubmed: 24318116 doi: 10.1152/ajplung.00311.2013
Zhou, X. et al. Neutrophils in acute lung injury. Front. Biosci. (Landmark Ed). 17, 2278–2283 (2012).
pubmed: 22652778 doi: 10.2741/4051
Kangelaris, K. N. et al. Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS. Am. J. Physiol. Lung Cell Mol. Physiol. 308, L1102–L1113 (2015).
pubmed: 25795726 pmcid: 4451399 doi: 10.1152/ajplung.00380.2014
Mitroulis, I. et al. Developmental endothelial locus-1 attenuates complement-dependent phagocytosis through inhibition of Mac-1-integrin. Thromb. Haemost. 111, 1004–1006 (2014).
pubmed: 24352615 doi: 10.1160/TH13-09-0794
Chavakis, T. et al. Hematopoietic progenitor cells as integrative hubs for adaptation to and fine-tuning of inflammation. Nat. Immunol. 20, 802–811 (2019).
pubmed: 31213716 pmcid: 6709414 doi: 10.1038/s41590-019-0402-5
Boll, I. T. et al. A kinetic model of granulocytopoiesis. Exp. Cell Res. 61, 147–152 (1970).
pubmed: 4914506 doi: 10.1016/0014-4827(70)90268-5
Lawrence, S. M. et al. Age-appropriate functions and dysfunctions of the neonatal neutrophil. Front. Pediatr. 5, 23 (2017).
pubmed: 28293548 pmcid: 5329040 doi: 10.3389/fped.2017.00023
Carr, R. Neutrophil production and function in newborn infants. Br. J. Haematol. 110, 18–28 (2000).
pubmed: 10930976 doi: 10.1046/j.1365-2141.2000.01992.x
Nakamura-Ishizu, A. et al. Extracellular matrix protein tenascin-C is required in the bone marrow microenvironment primed for hematopoietic regeneration. Blood. 119, 5429–5437 (2012).
pubmed: 22553313 pmcid: 3418770 doi: 10.1182/blood-2011-11-393645
Winkler, I. G. et al. Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self-renewal and chemoresistance. Nat. Med. 18, 1651–1657 (2012).
pubmed: 23086476 doi: 10.1038/nm.2969
Lee, G. Y. et al. Age-related differences in the bone marrow stem cell niche generate specialized microenvironments for the distinct regulation of normal hematopoietic and leukemia stem cells. Sci Rep. 9, 1007 (2019).
pubmed: 30700727 pmcid: 6353913 doi: 10.1038/s41598-018-36999-5
Penaloza, H. F. et al. Interleukin-10 plays a key role in the modulation of neutrophils recruitment and lung inflammation during infection by Streptococcus pneumoniae. Immunology. 146, 100–112 (2015).
pubmed: 26032199 pmcid: 4552505 doi: 10.1111/imm.12486
Andrade, E. B. et al. TLR2-induced IL-10 production impairs neutrophil recruitment to infected tissues during neonatal bacterial sepsis. J. Immunol. 191, 4759–4768 (2013).
pubmed: 24078699 doi: 10.4049/jimmunol.1301752
Lally, K. P. et al. The role of anti-tumor necrosis factor-alpha and interleukin-10 in protecting murine neonates from Escherichia coli sepsis. J. Pediatr. Surg. 35, 852–855 (2000).
pubmed: 10873025 doi: 10.1053/jpsu.2000.6862
Cusumano, V. et al. Interleukin-10 protects neonatal mice from lethal group B streptococcal infection. Infect. Immun. 64, 2850–2852 (1996).
pubmed: 8698523 pmcid: 174154 doi: 10.1128/iai.64.7.2850-2852.1996
Al-Mulla, Z. S. et al. Neutropenia in the neonate. Clin. Perinatol. 22, 711–739 (1995).
pubmed: 8521690 doi: 10.1016/S0095-5108(18)30277-X
Carr, R. et al. Low soluble FcRIII receptor demonstrates reduced neutrophil reserves in preterm neonates. Arch. Dis. Child Fetal Neonatal Ed. 83, F160 (2000).
pubmed: 11012271 pmcid: 1721145 doi: 10.1136/fn.83.2.F160
Rincon, J. C. et al. Cecal slurry injection in neonatal and adult mice. Methods Mol. Biol. 2321, 27–41 (2021).
pubmed: 34048005 pmcid: 8482797 doi: 10.1007/978-1-0716-1488-4_4
Nandi, M. et al. Rethinking animal models of sepsis—working towards improved clinical translation whilst integrating the 3Rs. Clin. Sci. 134, 1715–1734 (2020).
doi: 10.1042/CS20200679
Chaudhuri, J. et al. Granulocyte colony-stimulating factor for preterms with sepsis and neutropenia: a randomized controlled trial. J. Clin. Neonatol. 1, 202–206 (2012).
pubmed: 24027727 pmcid: 3762052 doi: 10.4103/2249-4847.105993
Carr, R. et al. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial. Lancet 373, 226–233 (2009).
pubmed: 19150703 doi: 10.1016/S0140-6736(09)60071-4
Starr, M. E. et al. A new cecal slurry preparation protocol with improved long-term reproducibility for animal models of sepsis. PLoS One 9, e115705 (2014).
pubmed: 25531402 pmcid: 4274114 doi: 10.1371/journal.pone.0115705
Brook, B. et al. Controlled mouse model for neonatal polymicrobial sepsis. J. Vis. Exp. 143, e58574 (2019).
Bradley, P. P. et al. Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood. 60, 618–622 (1982).
pubmed: 6286012 doi: 10.1182/blood.V60.3.618.618
Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).
pubmed: 11328886 pmcid: 55695 doi: 10.1093/nar/29.9.e45

Auteurs

Eleni Vergadi (E)

Department of Paediatrics, School of Medicine, University of Crete, Heraklion, Greece. eleni.vergadi@uoc.gr.
Institute of Molecular Biology and Biotechnology, IMMB, FORTH, Heraklion, Greece. eleni.vergadi@uoc.gr.

Ourania Kolliniati (O)

Institute of Molecular Biology and Biotechnology, IMMB, FORTH, Heraklion, Greece.
Department of Clinical Chemistry, School of Medicine, University of Crete, Heraklion, Greece.

Ioanna Lapi (I)

Institute of Molecular Biology and Biotechnology, IMMB, FORTH, Heraklion, Greece.
Department of Clinical Chemistry, School of Medicine, University of Crete, Heraklion, Greece.

Eleftheria Ieronymaki (E)

Institute of Molecular Biology and Biotechnology, IMMB, FORTH, Heraklion, Greece.
Department of Clinical Chemistry, School of Medicine, University of Crete, Heraklion, Greece.

Konstantina Lyroni (K)

Institute of Molecular Biology and Biotechnology, IMMB, FORTH, Heraklion, Greece.
Department of Clinical Chemistry, School of Medicine, University of Crete, Heraklion, Greece.

Vasileia Ismini Alexaki (VI)

Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.

Eleni Diamantaki (E)

Department of Intensive Care Medicine, School of Medicine, University of Crete, Heraklion, Greece.

Katerina Vaporidi (K)

Department of Intensive Care Medicine, School of Medicine, University of Crete, Heraklion, Greece.

Eleftheria Hatzidaki (E)

Department of Neonatology/Neonatal Intensive Care Unit, School of Medicine, University of Crete, Heraklion, Greece.

Helen A Papadaki (HA)

Department of Hematology, School of Medicine, University of Crete, Heraklion, Greece.

Emmanouil Galanakis (E)

Department of Paediatrics, School of Medicine, University of Crete, Heraklion, Greece.

George Hajishengallis (G)

Department of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Triantafyllos Chavakis (T)

Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.

Christos Tsatsanis (C)

Institute of Molecular Biology and Biotechnology, IMMB, FORTH, Heraklion, Greece.
Department of Clinical Chemistry, School of Medicine, University of Crete, Heraklion, Greece.

Classifications MeSH